Quanterix Corporation Foreign Currency Transaction Gain (Loss), Unrealized
Quanterix Corporation (QTRX) reported Foreign Currency Transaction Gain (Loss), Unrealized of -$63.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2023-05-09
- Quanterix Corporation foreign currency transaction gain (loss), unrealized for the quarter ending 2023-03-31 was -$63.00K.
- Quanterix Corporation foreign currency transaction gain (loss), unrealized for fiscal 2022 was $219.00K.
- Quanterix Corporation foreign currency transaction gain (loss), unrealized for fiscal 2021 was -$263.00K, a 1415.00% decline from fiscal 2020.
- Quanterix Corporation foreign currency transaction gain (loss), unrealized for fiscal 2020 was $20.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|
| 2023-03-31 | -$63.00K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $219.00K 10-K · filed 2023-03-06 | |
| 2021-12-31 | -$263.00K 10-K · filed 2023-03-06 | |
| 2020-12-31 | $20.00K 10-K · filed 2023-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |